supraclavicular lymph nodes swollen left side causes

3,4 However, if the injection site is higher up (ie closer to shoulder), it crosses into the supraclavicular lymph node draining area. 2 The mid-deltoid region, which drains into the deltopectoral lymph node, is the usual intramuscular injection site for the Pfizer vaccine. As a result of the acuteness of the clinical presentation, time-associated Pfizer vaccination, patient’s age and localised symptoms with no other underlying systemic conditions, the ‘wait and watch’ approach was chosen.Ĭases of vaccination-associated lymphadenopathy in ipsilateral axillary and supraclavicular regions have been reported, and these have been attributed to a local immune response. In the present case, the ipsilateral lymphadenopathy led to a detailed exploration of the regional lymphatic drainage. 1 Failure to take a proper history and examination can sometimes lead to further unnecessary diagnostic testing and follow-up examinations. Lymphadenopathy, whether localised (only one area involved) or generalised (enlarged in two or more non-contiguous areas), is clinically worrisome, particularly left supraclavicular lymphadenopathy (Virchow node). No ipsilateral axillary lymph nodes were palpable. One left supraclavicular lymph node, approximately 1 cm in size and tender to touch, was identified. The left deltoid region was locally tender at the site of injection. She initially thought that this could be due to burpees that she had been doing in the past two weeks. Approximately 3–5 hours after the onset of the soreness, she developed ipsilateral neck and chest soreness with a painful lump in the neck region. It is important to recognise a possible AEFI, as this can avoid unnecessary investigations and hence the burden on the patient and health system.Ī woman aged 40 years reported left arm soreness at the vaccination site within 48 hours after her second dose of Pfizer (Comirnaty) vaccination.

Among the 18,491 COVID-19 vaccine doses administered at our general practice, only one case of supraclavicular lymphadenopathy was recorded and reported on SAFEVAC as an adverse event following immunisation (AEFI). We report a case of COVID-19 vaccination–associated ipsilateral supraclavicular lymphadenopathy in the context of clinical management.

Supraclavicular lymph nodes swollen left side causes